Navigation Links
David H. Murdock Research Institute Taps Waters for Laboratory Technology

Strategic Partnership Provides Advanced Technology for Groundbreaking

Nutrition and Disease Research

KANNAPOLIS, N.C. and MILFORD, Mass., Oct. 15 /PRNewswire-FirstCall/ -- The David H. Murdock Research Institute (DHMRI), located at the North Carolina Research Campus in Kannapolis, NC, and Waters Corporation (NYSE: WAT) announced today that Waters(R) has been selected as the institute's primary supplier of analytical science solutions, including mass spectrometers, liquid chromatographs and associated scientific data management software.

"We selected Waters as a partner based on their breakthrough technologies and hands-on approach to customer service. The equipment that we've purchased from Waters is recognized as the most sophisticated laboratory equipment available," said David H. Murdock, DHMRI founder. "This large purchase continues the momentum we're building as a cutting-edge research facility sought after by some of the nation's brightest scientists, and positions us well for the future."

The new laboratory instrumentation will enable DHMRI's research programs in the areas of nutrition science and disease prevention and provide state-of the-art capabilities in proteomics research and metabolic profiling, among other key application areas

"Our respective organizations have a similar focus on pushing the limits of scientific discovery and productivity, as well as collaboration," said Art Caputo, Executive Vice President and President of the Waters Division. "As with all our partners, we are pleased to be working closely with DHMRI to help make scientific discovery at the facility possible."

Among the new mass spectrometers purchased by DHMRI are a number of Waters(R) SYNAPT(TM) High Definition Mass Spectrometers -- the first commercially-available mass spectrometer with the ability to analyze ions by their size, shape and charge in addition to mass -- as well as the Waters Quattro Premier(TM) XE and ACQUITY(R) SQD systems. DHMRI also purchased several ACQUITY UltraPerformance liquid chromatography (UPLC(R)) systems as their preferred inlet to the Institute's mass spectrometers.

About the David H. Murdock Research Institute

The David H. Murdock Research Institute was established as a public charity to support groundbreaking research at the North Carolina Research Campus. Funded through a private grant by David H. Murdock, DHMRI will host the world's top talent and resources - and promote a level of scientific collaboration never before possible. DHMRI is the first of its kind, housing a unique collection of state-of-the-art instrumentation in one central location.

For more information visit

About Waters Corporation

Waters Corporation creates business advantages for laboratory-dependent organizations by delivering practical and sustainable innovation to enable significant advancements in such areas as healthcare delivery, environmental management, food safety, and water quality worldwide.

Pioneering a connected portfolio of separations science, laboratory information management, mass spectrometry and thermal analysis, Waters technology breakthroughs and laboratory solutions provide an enduring platform for customer success.

With revenue of $1.47 billion in 2007 and 5,000 employees, Waters is driving scientific discovery and operational excellence for customers worldwide.

For more information visit

Waters, ACQUITY, UPLC, Synapt, and Quattro Premier XE are trademarks of Waters Corporation.


Waters Corporation:

Brian J. Murphy



Phyllis Beaver


SOURCE Waters Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. NSF International Acquires David Begg Associates
2. Former Banc of America Securities Analyst David Maris Comments on Decision by Biovail to Drop Its Claims Against Him; Denies That He is Cooperating With Biovail
3. Morria Biopharmaceuticals Plc Appoints Dr. Johnson Lau and Dr. David Sidransky to Board of Directors
4. David Barker, Former Illumina CSO, Joins GenVaults Scientific Advisory Board
5. Indevus Pharmaceuticals Announces Retirement of David B. Sharrock From Its Board of Directors
6. Dr. David Sidransky Appointed Chairman of Champions Biotechnology, Inc.
7. Immunosyn Corporation Names G. David Criner as CFO
8. Pasteuria Bioscience Taps New CEO David N. Duncan
9. David Mott Appointed Non Executive Director at Shire
10. Stereotaxis Appoints David Burkhardt, M.D. as Chief Medical Officer
11. Transgenomic Appoints David Pauluzzi to Board of Directors
Post Your Comments:
(Date:10/11/2017)... Palo Alto, CA, USA (PRWEB) , ... October 11, 2017 , ... ... is set to take place on 7th and 8th June 2018 in San Francisco, ... and policy influencers as well as several distinguished CEOs, board directors and government officials ...
(Date:10/11/2017)... -- VMS BioMarketing, a leading provider of patient support solutions, has ... (CNE) network, which will launch this week. The VMS CNEs ... professionals to enhance the patient care experience by delivering peer-to-peer ... care professionals to help women who have been diagnosed and ... ...
(Date:10/11/2017)... ... October 11, 2017 , ... Disappearing forests and increased emissions are ... 5.5 million people each year. Especially those living in larger cities are affected by ... in one of the most pollution-affected countries globally - decided to take action. , ...
(Date:10/11/2017)... ... October 11, 2017 , ... Singh Biotechnology today ... designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of Transcription 3) ... able to cross the cell membrane and bind intracellular STAT3 and inhibit its ...
Breaking Biology Technology:
(Date:4/6/2017)... -- Forecasts by Product Type (EAC), Biometrics, ... (Transportation & Logistics, Government & Public Sector, Utilities / ... Facility, Nuclear Power), Industrial, Retail, Business Organisation (BFSI), Hospitality ... looking for a definitive report on the $27.9bn Access ... ...
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
(Date:3/28/2017)... -- The report "Video Surveillance Market by ... Devices), Software (Video Analytics, VMS), and Service (VSaaS, Installation ... 2022", published by MarketsandMarkets, the market was valued at ... reach USD 75.64 Billion by 2022, at a CAGR ... considered for the study is 2016 and the forecast ...
Breaking Biology News(10 mins):